Parani Madasamy

Prof. Parani Madasamy

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2016 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SPSundar Poovitha
Sundar Poovitha
PMParani Madasamy
Parani Madasamy
α-amylase and α-glucosidase digest the carbohydrates and increase the postprandial glucose level in diabetic patients. Inhibiting the activity of these two enzymes can control postprandial hyperglycemia, and reduce the risk of developing diabetes. Bitter gourd or balsam pear is one of the important medicinal plants used for controlling postprandial hyperglycemia in diabetes patients. However, there is limited information available on the presence of α-amylase and α-glucosidase inhibiting compounds. In the current study, the protein extracts from the fruits of M. charantia var. charantia (MCC) and M. charantia var. muricata (MCM) were tested for α-amylase and α-glucosidase inhibiting activities in vitro, and glucose lowering activity after oral administration in vivo. The protein extract from both MCC and MCM inhibited the activity of α-amylase and α-glucosidase through competitive inhibition, which was on par with Acarbose as indicated by in vitro percentage of inhibition (66 to 69 %) and IC50 (0.26 to 0.29 mg/ml). Both the protein extracts significantly reduced peak blood glucose and area under the curve in Streptozotocin-induced diabetic rats, which were orally challenged with starch and sucrose. Protein extracts from the fruits of the two varieties of bitter gourd inhibited α-amylase and α-glucosidase in vitro and lowered the blood glucose level in vivo on par with Acarbose when orally administrated to Streptozotocin-induced diabetic rats. Further studies on mechanism of action and methods of safe and biologically active delivery will help to develop an anti-diabetic oral protein drug from these plants.

14 April 2016 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
PMParani Madasamy
Parani Madasamy
GLGiriraj Lokhande
Giriraj Lokhande
ASAnkur Singh
Ankur Singh
AGAkhilesh K Gaharwar
Akhilesh K Gaharwar

27 May 2004 in Plant Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
PMParani Madasamy
Parani Madasamy
SRSairam Rudrabhatla
Sairam Rudrabhatla
RMRachel Myers
Rachel Myers
HWHeatherbea Weirich
Heatherbea Weirich
BSBruce Smith
Bruce Smith
SGStephen L. Goldman
Stephen L. Goldman

1 March 2015 in Gene
Verified
Journal Article
Closed access
SVSophie Lorraine Vassou
Sophie Lorraine Vassou
GKG. Kusuma
G. Kusuma
PMParani Madasamy
Parani Madasamy

18 December 2004 in Theoretical and Applied Genetics
Verified
Journal Article
Closed access
PDF file
PMPreeti A. Mehta
Preeti A. Mehta
KSK. Sivaprakash
K. Sivaprakash
PMParani Madasamy
Parani Madasamy
GVGayatri Venkataraman
Gayatri Venkataraman
APAjay K. Parida
Ajay K. Parida

15 April 2011 in BMC Genomics
Verified
Journal Article
Open access
PDF file
PNPurushothaman Natarajan
Purushothaman Natarajan
PMParani Madasamy
Parani Madasamy
Jatropha curcas L. is an important non-edible oilseed crop with promising future in biodiesel production. However, factors like oil yield, oil composition, toxic compounds in oil cake, pests and diseases limit its commercial potential. Well established genetic engineering methods using cloned genes could be used to address these limitations. Earlier, 10,983 unigenes from Sanger sequencing of ESTs, and 3,484 unique assembled transcripts from 454 pyrosequencing of uncloned cDNAs were reported. In order to expedite the process of gene discovery, we have undertaken 454 pyrosequencing of normalized cDNAs prepared from roots, mature leaves, flowers, developing seeds, and embryos of J. curcas.